Type 1 diabetes mellitus is characterized by the autoimmune destruction of insulin‐secreting beta cells in the pancreas, and blood glucose levels of patients with diabetes mellitus are managed through exogenous insulin therapy to maintain normoglycemia [1, 2]. This evidence concerns the gene INS and diabetes mellitus.